AOLS Projected Dividend Yield
Aeolus Pharmaceuticals Inc ( OTCBB : AOLS )Aeolus Pharmaceuticals is a biopharmaceutical company developing a platform of compounds in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Co.'s primary compound, AEOL 10150 (10150), is being developed under contract as a medical countermeasure against the pulmonary sub-syndrome of acute radiation syndrome and the delayed effects of acute radiation exposure. Co. develops 10150 for the treatment of lung fibrosis, including idiopathic pulmonary fibrosis and other fibrotic disease as well as for use in combination with radiation therapy for cancer as a treatment to reduce side effects caused by radiation toxicity and improve local tumor control. 20 YEAR PERFORMANCE RESULTS |
AOLS Dividend History Detail AOLS Dividend News AOLS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |